A Complete Response in Small Cell Carcinoma of the Esophagus Treated by S-1/Cisplatin Combined Chemotherapy and Radiotherapy
โ Scribed by Masatsugu Hiraki; Masayuki Tanaka; Seiji Sato; Keita Kai; Kiyoto Morito; Kiichiro Kobayashi; Hirokazu Noshiro; Osamu Tokunaga; Kohji Miyazaki
- Book ID
- 107574753
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 425 KB
- Volume
- 41
- Category
- Article
- ISSN
- 1941-6628
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Surgery remains the treatment of choice for patients with esophageal squamous cell carcinoma (SCC), but survival rates have not improved over the past decades. The objective of this study was to evaluate the effect of multimodal therapy on resectability, on the overall and on diseas
A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)